skip to Main Content

What Our Sponsors Appreciate About Our Team

“Next to your expertise one of the things we appreciate most about Scimega
is your stable team, free of high employee turnover so common to other CROs.”

Denise Deakin

Co-Founding Partner / Co-Owner

In 1997, Denise along with her business partner of 22 years, Andrée Marceau, launched Scimega, Canada’s first oncology CRO.  Denise’s unwavering vision was to position Scimega as a unique Canadian CRO fully dedicated to the clinical development of novel oncology compounds. In her role as President, Denise’s primary focus was on developing successful business strategies, leveraging opportunities and overseeing the company’s business development initiatives.  Today, Denise remains a partner in the business with an active interest in Scimega’s long term success.

Andrée Marceau

Co-Founding Partner / Co-Owner

In 1997, Andrée along with her business partner Denise Deakin launched Scimega, Canada’s first oncology CRO. In her role as General Manager Andrée’s unwavering vision was to develop the high caliber business operations necessary for Scimega’s success as Canada’s premier oncology CRO. Together with Denise, she crafted business strategies & leveraged opportunities. Today, Andrée remains a partner at Scimega with an active interest in the company’s long term success.

Julie Martin

CEO / Co-Owner

Julie has been part of the team at Scimega, since 2013.  Her passion for the business stems from knowing its expert oncology clinical development services add distinct value to industry stakeholders at a time when it’s needed most. As CEO, her vision is to secure the company’s long term success by leveraging her in-depth industry expertise & business acumen.

Julie equates that success with setting a clear vision for the organization’s continued sense of purpose. She is responsible for developing successful business strategies & leveraging industry opportunities all of which support the common vision she shares with her team. Julie’s leadership & collaboration with the managing Board of Directors, esteemed colleagues with whom she has worked alongside for many years, ensure the business excellence upon which Scimega has built its reputation.

As CEO, Julie plays a vital role in promoting Scimega’s expertise and showcasing Canada’s attributes as a formidable partner in global oncology drug development.

Catherine Ménard

Director of Quality and Human Resources

Catherine currently serves as Scimega’s Director of Quality and Human Resources. She is dedicated to the successful conduct of oncology clinical trials in Canada and is responsible for building a talented, stable and highly motivated workforce at the company.

Catherine joined Scimega in 2006 as a Clinical Research Associate. She has over 19 years of experience in medical research, mainly in oncology clinical research and has worked in both the hospital and biopharmaceutical settings. She began her research activities in functional brain imaging and later in stem cell research with top researchers in Canada. She also played a key role in the management of a European multicenter oncology research project at the oncology hospital, Jules Bordet Institute in Brussels.

She holds a Masters degree in Neurosciences from University of Montreal and is a member of Scimega’s Board of Directors.

Geneviève Piché

Director of Finance

Geneviève currently serves as the Director of Finance and is responsible for all financial aspects of the company. In addition, she also oversees all the IT requirements for the company.

Geneviève joined Scimega in 2010 and brings over 13 years of experience in accounting, financial analysis and payroll administration. In her role as Director of Finance, she is responsible for leading the finance organization and supporting strategic planning and business operations. As a member of the Board of Directors, she also supports planning and execution of enhancements to support company growth.

Marie-Claude Bélanger

Director, Clinical Operations

Marie-Claude has 24 years of oncology experience as a healthcare and clinical research professional. This includes an extensive & impressive track record in the conduct and oversight of multi-center global oncology clinical trials. Marie-Claude, who has been part of the Scimega team since 2016, is responsible for Clinical Operations. In her leadership role, Marie-Claude is dedicated to ensuring the operations team consistently produces stellar performance metrics, key to our clients’ success. As a corporate Director, Marie-Claude is an active member of Scimega’s managing Board of Directors.


4-out of-5 Site evaluations rate Scimega services as superior compared to other CROs worked with.

Receive updates from our blog, podcasts and resource library.

Sign up to Canadian Oncology Clinical Trial News

Back To Top